Stay updated on Biomarker Analysis in High PD-L1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the Biomarker Analysis in High PD-L1 NSCLC Clinical Trial page.

Latest updates to the Biomarker Analysis in High PD-L1 NSCLC Clinical Trial page
- Check5 days agoChange DetectedAdded revision entry v3.3.4 to the Record History. Removed v3.3.3 from the version list.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the Record History, and 'HHS Vulnerability Disclosure' along with the previous 'Revision: v3.3.2' were removed from the footer; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check48 days agoChange DetectedThe Record History now includes a new revision entry: v3.3.2 has been added. The previous revision v3.3.1 has been removed.SummaryDifference0.1%

- Check56 days agoChange DetectedThe Record History shows an added Revision v3.3.1 and the removal of Revision v3.2.0.SummaryDifference0.1%

- Check63 days agoChange DetectedNotice about lapse in government funding and potential delays was removed, eliminating guidance on operating status and where to check for updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check77 days agoChange DetectedVersion history shows updates to Recruitment Status and Study Status across versions 2–5, and the latest version includes a Study Design change.SummaryDifference0.1%

Stay in the know with updates to Biomarker Analysis in High PD-L1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker Analysis in High PD-L1 NSCLC Clinical Trial page.